We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $178B
1-Year Est. Return 37.23%
This Fund
S&P 500
This Quarter Est. Return
+1.45%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$77.7B
AUM Growth
+$28.1B
Cap. Flow
+$27.7B
Cap. Flow %
35.64%
Top 10 Hldgs %
8.03%
Holding
3,834
New
1,974
Increased
1,386
Reduced
336
Closed
47

Sector Composition

Rank Sector Weight
1 Technology 15.99%
2 Financials 14.9%
3 Industrials 12.22%
4 Consumer Discretionary 10.07%
5 Healthcare 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LSTA icon
3476
Lisata Therapeutics
LSTA
$9.55M
$4K ﹤0.01%
+109
New +$4.24K
OCC icon
3477
Optical Cable Corp
OCC
$143M
$4K ﹤0.01%
+1,006
New +$3.71K
OGEN icon
3478
Oragenics
OGEN
$2.48M
$4K ﹤0.01%
+4
New +$3.34K
PAVM icon
3479
PAVmed
PAVM
$33.9M
$4K ﹤0.01%
+10
New +$4.57K
RCMT icon
3480
RCM Technologies
RCMT
$208M
$4K ﹤0.01%
+1,423
New +$4.58K
REKR icon
3481
Rekor Systems
REKR
$91.7M
$4K ﹤0.01%
+1,858
New +$5.64K
RKDA icon
3482
Arcadia Biosciences
RKDA
$1.52M
$4K ﹤0.01%
+21
New +$4.03K
RDNW
3483
RideNow Group
RDNW
$262M
$4K ﹤0.01%
+67
New +$5.08K
RRBI icon
3484
Red River Bancshares
RRBI
$659M
$4K ﹤0.01%
+103
New +$4.71K
SLNO
3485
DELISTED
Soleno Therapeutics
SLNO
$4K ﹤0.01%
+172
New +$5.49K
STRM
3486
DELISTED
Streamline Health Solutions
STRM
$4K ﹤0.01%
+228
New +$4.72K
TRVI icon
3487
Trevi Therapeutics
TRVI
$2.64B
$4K ﹤0.01%
+986
New +$5.36K
VALU icon
3488
Value Line
VALU
$361M
$4K ﹤0.01%
+190
New +$4.82K
VTSI icon
3489
VirTra
VTSI
$34.5M
$4K ﹤0.01%
+1,392
New +$3.52K
XELB icon
3490
Xcel Brands
XELB
$6.6M
$4K ﹤0.01%
+206
New +$4.2K
VBFC
3491
DELISTED
Village Bank and Trust Financial Corp.
VBFC
$4K ﹤0.01%
+127
New +$4.34K
BCOW
3492
DELISTED
1895 Bancorp of Wisconsin
BCOW
$4K ﹤0.01%
+512
New +$3.66K
FUV
3493
DELISTED
Arcimoto, Inc. Common Stock
FUV
$4K ﹤0.01%
+61
New +$3.86K
GMDA
3494
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$4K ﹤0.01%
1,000
UFAB
3495
DELISTED
Unique Fabricating, Inc.
UFAB
$4K ﹤0.01%
+1,543
New +$4.22K
AXLA
3496
DELISTED
Axcella Health Inc. Common Stock
AXLA
$4K ﹤0.01%
+26
New +$4.82K
NMTR
3497
DELISTED
9 Meters Biopharma
NMTR
$4K ﹤0.01%
+207
New +$4.18K
OIG
3498
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$4K ﹤0.01%
+131
New +$4.01K
CHRA
3499
DELISTED
Charah Solutions, Inc Common Stock
CHRA
$4K ﹤0.01%
+168
New +$6.62K
RBCN
3500
DELISTED
Rubicon Technology, Inc.
RBCN
$4K ﹤0.01%
+404
New +$3.63K

Similar funds

Victory Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Victory Capital Management held 3,834 positions worth $77.7B, up 57% from $49.6B the previous quarter. Its ten largest holdings account for 8% of the portfolio.

Victory Capital Management deployed $27.7B of net new capital in Q3 2019, opening 1,974 new positions and adding to 1,386 existing holdings. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,479,630 shares worth $316M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Reliance Steel & Aluminium, an estimated $98.7M trimmed.

  • Victory Capital Management's largest Q3 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,479,630 shares worth $316M.
  • Victory Capital Management added most to Microsoft in Q3 2019, an estimated $891M increase.
  • Victory Capital Management's biggest Q3 2019 reduction was Reliance Steel & Aluminium, cutting an estimated $98.7M.
  • Victory Capital Management fully exited Electronics for Imaging in Q3 2019, selling an estimated $61.5M.
  • Victory Capital Management's ten largest holdings make up 8% of its $77.7B portfolio in Q3 2019.
  • Victory Capital Management opened 1,974 new positions and closed 47 in Q3 2019.
  • Victory Capital Management's portfolio value rose 57% quarter-over-quarter to $77.7B.

Based on Victory Capital Management's 13F filing for Q3 2019, filed 12 Nov 2019.